Zymeworks Inc. (ZYME) stock
ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value
$26.47−2.60 (-8.94%)
Close on Nov 12, 2026Market cap $1.88BP/E 50.9Yield –
Zymeworks statistics
87 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 1, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 14.63
- 2.38
Enterprise valuationIndustry
- EV / Sales
- 7.38
- 2.65
- EV / EBIT
- 44.45
- 19.15
Share statisticsIndustry
- Shares Change (YoY)
- -1.26%
- 10.9%
- Shares Change (QoQ)
- -0.33%
- 0.48%
- Float
- 29M
- 49M
- Shares Held by Insiders
- 58.9%
- 12.1%
- Shares Held by Institutions
- 98.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 6M
- –
- Short Interest Change
- 6.04%
- -0.80%
- Short % of Float
- 20.3%
- 9.06%
- Short % of Shares Outstanding
- 8.34%
- 6.30%
- Days to Cover
- 4.25
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $31.97
- –
- 52-Week Low
- $18.20
- –
- 20-Day Moving Average
- $28.56
- –
- 50-Day Moving Average
- $27.48
- –
- 200-Day Moving Average
- $25.48
- –
- Average True Range (14)
- $1.38
- –
- Price Change (1 Week)
- -6.04%
- -0.58%
- Price Change (1 Month)
- 16.0%
- -0.28%
- Price Change (3 Months)
- 12.8%
- -17.1%
- Price Change (6 Months)
- 18.3%
- -20.1%
- Price Change (YTD)
- 10.4%
- -20.1%
- Price Change (1 Year)
- 61.1%
- -19.3%
- Price Change (3 Years)
- 299.9%
- -22.2%
- Price Change (5 Years)
- 44.3%
- -76.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 883,540
- –
- Relative Volume
- 1.11
- 0.73
- Relative Strength Index (14)
- 52.8
- 47.7
- Volatility (1 Year)
- 54.1%
- 80.2%
- Beta (5 Years)
- 0.84
- 1.08
MarginsIndustry
- Pretax Margin
- 15.1%
- -11.8%
- EBITDA Margin
- 16.6%
- -27.7%
- FCF Margin
- -42.4%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 15.0%
- -51.3%
- Return on Assets (ROA)
- 5.50%
- -40.7%
- Return on Invested Capital (ROIC)
- 21.4%
- -32.9%
- Return on Capital Employed (ROCE)
- 4.35%
- -38.1%
Financial positionIndustry
- Current Ratio
- 3.30
- 3.30
- Quick Ratio
- 3.19
- 2.40
GrowthIndustry
- Revenue Growth (YoY)
- 97.8%
- 7.26%
- Revenue Growth (3Y CAGR)
- -36.4%
- 2.25%
- Revenue Growth (5Y CAGR)
- 22.2%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.34
- 0.40
- Revenue Per Employee
- $1.01M
- $429.38K
- Profits Per Employee
- $164.05K
- -$683.67K
- Employee Count
- 264
- 75
- WACC
- 9.10%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- $40.12M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $100.46M
- $16.56M
- Net Cash Per Share
- $1.42
- $0.71
- Equity (Book Value)
- $258.25M
- $52.23M
- Book Value Per Share
- $3.64
- $1.50
- Tangible Book Value
- $141.03M
- $26.10M
- Working Capital
- $370.94M
- $78.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$870.00K
- -$944.00K
- FCF Per Share
- -$1.59
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 2.10%
- -20.1%
- FCF Yield
- -5.47%
- -9.14%
- Buyback Yield
- 8.03%
- -0.69%
- Shareholder Yield
- 8.03%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$3.19M
- $74.00K
- Effective Tax Rate
- -7.94%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $6.53
- $19.34
- Graham Upside
- -77.6%
- -46.9%
- Altman Z-Score
- 0.87
- 0.31
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ZYME | S&P 500 | Difference | ZYME per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.5% | -2.7% | +7.2 pts | ||
| 3 months | +6.2% | -1.7% | +7.9 pts | ||
| Year to date | +0.5% | +11.9% | −11.4 pts | ||
| 1 year | +36.7% | +12.0% | +24.7 pts | ||
| 3 years | +263.1% | +78.2% | +184.9 pts | +53.7% | +21.2% |
| 5 years | +31.4% | +73.2% | −41.9 pts | +5.6% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
6M ZYME shares were sold short on Oct 30, 2026, up 6.0% from the previous report, or 20.29% of the shares available to trade. At recent volumes it would take 4.3 days to buy them back. Over the last 20 sessions, 58.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,914,601 | +6.0% | 1,392,562 | 4.3 |
| Oct 15, 2026 | 5,577,540 | +5.4% | 1,279,838 | 4.4 |
| Sep 30, 2026 | 5,291,136 | +7.1% | 953,928 | 5.5 |
| Sep 15, 2026 | 4,939,072 | +4.5% | 619,914 | 8.0 |
| Aug 31, 2026 | 4,724,831 | +4.1% | 827,575 | 5.7 |
| Aug 14, 2026 | 4,538,353 | +10.5% | 533,925 | 8.5 |
| Jul 31, 2026 | 4,106,590 | +0.1% | 376,796 | 10.9 |
| Jul 15, 2026 | 4,102,257 | -6.0% | 542,279 | 7.6 |
| Jun 30, 2026 | 4,364,318 | -2.7% | 704,780 | 6.2 |
| Jun 15, 2026 | 4,485,642 | -0.9% | 804,667 | 5.6 |
| May 29, 2026 | 4,527,668 | +1.3% | 594,680 | 7.6 |
| May 15, 2026 | 4,470,973 | -3.8% | 673,335 | 6.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?